Virtus ETF Advisers’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,415
Closed -$66.6K 380
2024
Q4
$66.6K Sell
1,415
-332
-19% -$15.6K 0.03% 407
2024
Q3
$92.2K Buy
1,747
+30
+2% +$1.58K 0.04% 387
2024
Q2
$93K Sell
1,717
-650
-27% -$35.2K 0.05% 344
2024
Q1
$166K Sell
2,367
-162
-6% -$11.4K 0.09% 311
2023
Q4
$211K Sell
2,529
-295
-10% -$24.6K 0.13% 282
2023
Q3
$83.2K Sell
2,824
-282
-9% -$8.31K 0.05% 352
2023
Q2
$101K Buy
3,106
+661
+27% +$21.6K 0.06% 373
2023
Q1
$86K Sell
2,445
-938
-28% -$33K 0.05% 375
2022
Q4
$155K Buy
3,383
+718
+27% +$32.9K 0.08% 337
2022
Q3
$129K Buy
2,665
+18
+0.7% +$871 0.05% 380
2022
Q2
$104K Sell
2,647
-1,529
-37% -$60.1K 0.04% 423
2022
Q1
$154K Sell
4,176
-249
-6% -$9.18K 0.07% 224
2021
Q4
$202K Sell
4,425
-5,298
-54% -$242K 0.08% 204
2021
Q3
$348K Sell
9,723
-514
-5% -$18.4K 0.15% 185
2021
Q2
$203K Sell
10,237
-3,899
-28% -$77.3K 0.08% 334
2021
Q1
$329K Buy
14,136
+247
+2% +$5.75K 0.14% 223
2020
Q4
$289K Sell
13,889
-528
-4% -$11K 0.12% 229
2020
Q3
$312K Sell
14,417
-1,971
-12% -$42.7K 0.16% 211
2020
Q2
$386K Sell
16,388
-17,366
-51% -$409K 0.18% 213
2020
Q1
$398K Sell
33,754
-4,932
-13% -$58.2K 0.16% 198
2019
Q4
$410K Buy
38,686
+12,199
+46% +$129K 0.07% 245
2019
Q3
$301K Sell
26,487
-1,475
-5% -$16.8K 0.06% 199
2019
Q2
$315K Sell
27,962
-5,796
-17% -$65.3K 0.07% 202
2019
Q1
$273K Sell
33,758
-3,729
-10% -$30.2K 0.58% 67
2018
Q4
$237K Sell
37,487
-12,590
-25% -$79.6K 0.04% 167
2018
Q3
$493K Sell
50,077
-35,803
-42% -$352K 0.05% 125
2018
Q2
$713K Sell
85,880
-7,429
-8% -$61.7K 0.63% 96
2018
Q1
$672K Buy
93,309
+50,664
+119% +$365K 0.58% 97
2017
Q4
$348K Buy
42,645
+19,250
+82% +$157K 0.44% 93
2017
Q3
$339K Buy
23,395
+2,140
+10% +$31K 0.05% 125
2017
Q2
$257K Sell
21,255
-3,624
-15% -$43.8K 0.04% 141
2017
Q1
$320K Buy
24,879
+2,385
+11% +$30.7K 0.06% 130
2016
Q4
$273K Sell
22,494
-6,885
-23% -$83.6K 0.08% 118
2016
Q3
$270K Hold
29,379
0.13% 111
2016
Q2
$279K Buy
29,379
+7,255
+33% +$68.9K 0.21% 68
2016
Q1
$156K Buy
+22,124
New +$156K 0.21% 116